SCHEDULE 13G/A: Baker Bros. Advisors and Affiliates Disclose 7.2% Stake in Celcuity Inc.

Baker Bros. Advisors LP and its affiliates have reported a beneficial ownership of 7.2% of Celcuity Inc.'s common stock as of December 31, 2024, according to a recent Schedule 13G amendment.

Summary

• Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, and Felix J. Baker (collectively, the "Reporting Persons") have filed an Amendment No. 1 to their Schedule 13G for Celcuity Inc.
• As of December 31, 2024, the Reporting Persons beneficially own an aggregate of 2,678,553 shares of Celcuity Inc. Common Stock.
• This ownership represents 7.2% of the outstanding Common Stock, based on 37,129,556 shares outstanding as of November 8, 2024, as reported in Celcuity Inc.'s Form 10-Q.
• The shares are held through Baker Brothers Life Sciences, L.P. (6.7% or 2,476,137 shares) and 667, L.P. (0.5% or 202,416 shares).
• The Reporting Persons also hold Pre-funded Warrants with an exercise price of $0.001 per share, but cannot currently exercise them due to a 4.99% beneficial ownership limitation, which can be increased to 19.99% with 61 days' notice.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of beneficial ownership by a significant institutional investor. While the stake itself is a positive signal of investor confidence, the document provides no new operational or financial performance details for the issuer. The limitations on warrant exercise introduce a minor complexity.

Positives

• A significant stake (7.2%) held by a prominent investment firm like Baker Bros. Advisors can signal confidence in Celcuity Inc.'s long-term prospects to other investors.
• The holding is stated to be in the ordinary course of business, indicating a passive investment rather than an activist stance.

Negatives

• The inability to currently exercise Pre-funded Warrants due to beneficial ownership limitations means the Reporting Persons cannot immediately increase their stake through these instruments, potentially limiting their flexibility.

Risks

• The beneficial ownership limitation on Pre-funded Warrants (currently 4.99%, extendable to 19.99% after 61 days' notice) restricts the Reporting Persons' ability to fully convert these warrants into common stock, which could impact their potential upside from these instruments.

Future Outlook

NA

Industry Context

This filing indicates a significant institutional investment in Celcuity Inc., a company whose primary business is not detailed in this specific filing but is typically in the biotechnology or life sciences sector given the nature of Baker Bros. Advisors' investments. Such an investment by a specialized fund can be seen as a vote of confidence within the broader life sciences investment community.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a reputable institutional investor like Baker Bros. Advisors may instill confidence and potentially attract other investors, positively impacting shareholder sentiment.
• Company Management: The presence of a large, passive institutional investor may provide stability and long-term focus, as the filing explicitly states the investment is not for control purposes.

Key Dates

Keywords

Celcuity Inc., Baker Bros. Advisors, Schedule 13G, beneficial ownership, common stock, pre-funded warrants, institutional investment, SEC filing, equity stake